Trial Profile
Chidamide with Rituximab for Relapsed/Refratory Germinal Center subtype of Diffuse Large B Cell Lymphoma
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Jul 2016
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Tucidinostat (Primary)
- Indications B-cell lymphoma
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 01 Jul 2016 New trial record